Key result
Gestational diabetes in a rat model triggered postpartum concentric cardiac hypertrophy, significantly increasing left ventricular mass compared to non-pregnant controls (941 vs 750 mg, p<0.05), likely via calcineurin/NFAT signaling activation.
Why the study?
It was unclear whether gestational diabetes mellitus initiates cardiac hypertrophy and dysfunction later in life, and what mechanisms underlie this phenotype.
Does gestational diabetes trigger postpartum cardiac hypertrophy via calcineurin/NFAT signaling in a rat model?
Does gestational diabetes trigger postpartum cardiac hypertrophy via calcineurin/NFAT signaling in a rat model?
Gestational diabetes accelerates pathological cardiac remodeling postpartum in a rat model, likely via calcineurin/NFAT signaling activation.
Answers are grounded in this paper and cite their sources.
GDM may trigger postpartum cardiac hypertrophy in this rat model; leaves open human relevance and mechanisms for clinical translation.
Population-based studies identified an association between a prior pregnancy complicated by gestational diabetes mellitus (GDM) and cardiac hypertrophy and dysfunction later in life. It is however unclear whether GDM initiates this phenotype and what are the underlying mechanisms. We addressed these questions by using female rats that express human amylin (HIP rats) as a GDM model and their wild-type (WT) littermates as the normal pregnancy model. Pregnant and two months postpartum HIP females had increased left-ventricular mass and wall thickness compared to non-pregnant HIP females, which indicates the presence of concentric hypertrophy. These parameters were unchanged in WT females during both pregnancy and postpartum periods. Hypertrophic Ca 2+ -dependent calcineurin/NFAT signaling was stimulated two months after giving birth in HIP females but not in the WT. In contrast, the CaMKII/HDAC hypertrophy pathway was active immediately after giving birth and returned to the baseline by two months postpartum in both WT and HIP females. Myocytes from two months postpartum HIP females exhibited slower Ca 2+ transient relaxation and higher diastolic Ca 2+ levels, which may explain calcineurin activation. No such effects occurred in the WT. These results suggest that a GDM-complicated pregnancy accelerates the development of pathological cardiac remodeling likely through activation of calcineurin/NFAT signaling.
No takes yet. Share an insight, caveat, or question.
Verma et al. (2021) studied Gestational diabetes mellitus and postpartum cardiac hypertrophy (n=87). Gestational diabetes mellitus (HIP rat pregnancy model) vs. Non-pregnant HIP controls and normal pregnancy (WT rats) was evaluated on Left ventricular mass at 2 months postpartum in HIP rats (p=<0.05). Gestational diabetes in a rat model triggered postpartum concentric cardiac hypertrophy, significantly increasing left ventricular mass compared to non-pregnant controls (941 vs 750 mg, p<0.05), likely via calcineurin/NFAT signaling activation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: